|
|
||||||||
|
||||||||
|
||||||||
|
Michael Abrams, MA Managing Partner Numerof & Associates Michael Abrams is co-founder, Vice President and Managing Partner of Numerof. Over the last 25 years he has built a portfolio of strategy and business performance successes as an internal and external consultant to Fortune 500 corporations. Leveraging the corporate management experience he acquired prior to founding Numerof, Michael has shaped the development of Numerof’s approach, including the firm’s emphasis on innovative and realistic strategies for changing markets, as well as rigor in managing the complex change necessary for improving organizational performance. While appreciating the art of running a business, Michael maximizes the science of it. He is an advocate for data-based business decision-making, helping clients develop structured tools and guidelines that support important decisions. He encourages objectivity and practicality in the design and installation of database management, decision support systems, and technology integration, ensuring that they truly support business objectives. Mr. Abrams completed his doctoral work in business policy at St. Louis University and received his MA from George Washington University in Washington, DC. He co-authored Healthcare at a Turning Point: A Roadmap for Change, and his articles have appeared in more than a dozen leading business journals. He has served as an adjunct faculty member at Washington University, Webster University in St. Louis, and LaSalle University School of Business Administration in Philadelphia. Michael has taught MBA courses in strategy, management, program planning and evaluation, quantitative decision making, and market analysis. |
||||||||
|
David Axene, FSA, FCA, CERA, MAAA President & Consulting Actuary Axene Health Partners, LLC Mr. Axene started Axene Health Partners, LLC in 2003 after a successful consulting career at Ernst & Young, LLP and Milliman & Robertson, Inc. Mr. Axene is an internationally recognized health consultant providing consulting services to all types of health care organizations. At Ernst & Young, he was responsible for the firm’s health actuaries. He was an Equity Principal with the well-known actuarial firm Milliman & Robertson, Inc. (i.e., now Milliman USA) where he led their healthcare management consulting activities, including founding their Care Guidelines division. Prior to beginning his consulting career in 1978, he held several positions in the insurance industry specializing in the health insurance area. He is recognized as a strategist and thought leader and is a frequent speaker and writer on healthcare issues. He is a Fellow of the Society of Actuaries, a Chartered Enterprise Risk Analyst, a Fellow of the Conference of Consulting Actuaries, and a Member of the American Academy of Actuaries. He previously served as Chair of the Society of Actuaries Health Section Council and the Entrepreneurial Actuaries Section. He is a certified ARIAS-US arbitrator In addition to his actuarial credentials, Mr. Axene earned an MS degree in Applied Mathematics from the University of Washington, and a BS degree in Physics and Engineering from Seattle Pacific University. |
||||||||
|
Peter Alan Benn, PhD Professor, Genetics and Genome Sciences University of Connecticut Health Center Peter Alan Benn, PhD, is a tenured professor and laboratory director at the University of Connecticut Health Center. Dr. Benn’s clinical responsibilities have included oversight of the cytogenetics and prenatal screening laboratories. His research interests have been mostly focused on various aspects of prenatal testing and diagnosis, most recently the introduction of non-invasive prenatal testing. Dr. Benn is chair of the International Society for Prenatal Diagnosis (ISPD)’s Special Interest Group (SIG) for Prenatal Screening, and co-editor of the Society’s Newsletter. In addition, he has organized pre-conference courses for the past several ISPD meetings. He is also Chair of the Committee for Chromosome Abnormality Screening, which has developed Position Statements including guidance for the appropriate use of genomic sequencing methods in non-invasive prenatal testing. |
||||||||
|
Vicki DeBaca Vice President Health and Provider Services Sharp Health Care/ Sharp Rees Stealy Medical Group Vicki DeBaca, DNS, RN is the Vice President of Health and Provider Services for Sharp Rees-Stealy Medical Centers in San Diego, California. She has an extensive nursing background including professional experience in acute hospitals, ambulatory settings as well as in marketing and managed care organizations. Vicki also teaches nursing courses in academic settings and has considerable experience in continuing education programs. She received her doctorate in Nursing Science from the University of San Diego. |
||||||||
|
Maude Carmel, MD, FRCS(C) Assistant Professor, Department of Urology UT Southwestern Medical Center A specialist in female urology and pelvic reconstructive surgery, Dr. Carmel is a member of the Female Urology team in UT Southwestern Medical Center’s Department of Urology. Life can be very limited and isolated for people with moderate to severe urinary and bladder-related problems such as incontinence, pelvic organ prolapse, neurogenic bladder, fistulas, and complications of transvaginal mesh. Patients who suffer from conditions like these will be glad to know that urologist Maude Carmel, MD, offers the most advanced therapies, technologies, and techniques to successfully treat them. She performs all types of related surgeries – vaginal, robotically assisted, and abdominal. Fellowship-trained in female pelvic medicine and reconstructive surgery, Dr. Carmel is also able to treat complex cases such as patients with recurrent problems, failed previous repairs, and complications from previous treatments, including those from transvaginal mesh. Because each patient’s issues, anatomy, and treatment goals are unique, Dr. Carmel says she strives to educate patients about their options and lets them decide which option will fit them best. |
||||||||
|
Rajat Deo, MD Assistant Professor of Medicine University of Pennsylvania Rajat Deo, MD, MTR is a cardiac electrophysiologist at the University of Pennsylvania School of Medicine. His clinical interests focus on the care and management of patients with atrial fibrillation. He also serves as the team cardiologist for all University of Pennsylvania athletics and evaluates patients at high risk for sudden cardiac death. Dr. Deo has an active research program that is funded by the National Institutes of Health. He aims to understand the impact of atrial fibrillation in various populations and is involved in various clinical trials that are evaluating oral anticoagulants and catheter ablation. He is also involved with identifying novel risk factors and genetic variants that can enhance the prediction of sudden cardiac death in low and intermediate risk populations. Dr. Deo graduated from MIT before completing medical school at the University of Michigan. He was a resident at the University of Texas Southwestern Medical Center, cardiology fellow at the University of California, San Francisco and completed his electrophysiology fellowship at the Johns Hopkins Hospital. |
||||||||
|
Donald A. Donahue, Jr., DHEd, MBA, FACHE Associate Professor - University of Maryland University College Managing Partner – Diogene Group LLC Donald A. Donahue, Jr., DHEd, MBA, FACHE is a founding partner of the Diogene Group LLP consulting in healthcare, medical readiness, education, training, operations, analysis, program evaluation, and services delivery. He is currently an Adjunct Associate Professor of Health Administration at the University of Maryland University College and Adjunct Assistant Professor Health Administration at the University of Maryland Baltimore County. Dr. Donahue is a member of several medical associations and provides expert advice as a consultant and presenter with numerous organizations and has published countless articles in various medical journals focusing on a range of subjects from case management to medical emergency response approaches. Dr. Donahue has earned multiple degrees, served in the United States Army for over 20 years, has received ample awards and continues to be recognized as a volunteer in the community today. |
||||||||
|
Stanley Fiel, MD Regional Chair, Department of Medicine Atlantic Health System Dr. Fiel attended the Medical College of Pennsylvania, completed his residency training at Temple University Hospital, and undertook his fellowship training in pulmonary and critical care medicine at the Hospital of the University of Pennsylvania. Prior to joining the Atlantic Health System team in 2003, he was the chairman of Pulmonary and Critical Care Medicine at Hahnemann and Drexel Schools of Medicine. Dr. Fiel is world-renowned for his expertise in both Chronic Obstructive Pulmonary Disease and the management of Cystic Fibrosis in adults. |
||||||||
|
H. James Ford, III, MD Assistant Professor of Medicine University of North Carolina at Chapel Hill H. James Ford, III, MD, is an Assistant Professor of Medicine as well as the Director of the Pulmonary Hypertension Program at the University of North Carolina at Chapel Hill School of Medicine. Dr. Ford is also the Co-Medical Director of the universities Pulmonary Clinic. He focuses primarily on clinical and translational research in the area of Pulmonary Arterial Hypertension (PAH). Dr. Ford is involved in numerous multicenter clinical trials investigating therapies for PAH, as well as investigator initiated studies examining the treatment of PAH in the setting of sarcoidosis, cirrhosis, and interstitial lung disease (pulmonary fibrosis). He also investigates the role of inflammatory and procoagulant biomarkers in the pathogenesis and clinical manifestations of PAH. Dr. Ford has published clinical trial results in articles of various medical journals focusing on the diagnosis and treatment options for PAH. |
||||||||
|
Philip Friedlander, MD, PhD Assistant Professor of Medicine Hematology and Medical Oncology Mount Sinai Hospital Dr. Friedlander received medical school training at Columbia University where he obtained his MD and PhD degree in Biology. He remained at Columbia Presbyterian Medical Center to complete his postdoctoral training in Internal Medicine and subsequently completed a clinical fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center. He then joined the faculty of the Dana Farber Cancer Institute/Brigham and Women’s Hospital as an attending physician within the Melanoma and Cutaneous Oncology Programs and as an Instructor of Medicine at Harvard Medical School. His clinical interests include the development of targeted therapies and immunotherapies for patients with melanoma, merkel cell carcinoma, advanced cutaneous squamous cell carcinoma, basal cell carcinoma, and sebaceous gland tumors. At the Dana Farber Cancer Institute he acted as a principal investigator testing novel therapeutic approaches for melanoma including PARP inhibition, hsp90 inhibition, anti-apoptotic approaches, and immune modulatory and anti-CTLA4 based strategies. He investigated in non-melanoma skin cancers novel therapeutic strategies such as hedgehog signaling pathway inhibition in advanced basal cell carcinoma. As a member of the Division of Hematology/Medical Oncology and as the Director of the Melanoma Medical Oncology Program at Mount Sinai, he will be caring for patients with cutaneous malignancies and continue working to develop collaborative translational and basic science projects and treatments for patients with cutaneous malignancies. |
||||||||
|
Kulleni Gebreyes, MD, MBA Director, Health Industries Advisory Practice, PricewaterhouseCoopers, LLP A physician leader with more than 16 years of experience across the commercial and public sector. Dr. Gebreyes is a board certified emergency medicine physician who has expertise in physician engagement and education, adoption and implementation of health information technology, quality and performance improvement, and compliance and assurance. Dr. Gebreyes has led numerous public-private sector collaborations across payer and provider enterprises in preparation for health care industry convergence. She leads initiatives which are designed to improve quality while reducing cost of care. She has deep insight into the functional requirements of complex systems operated by providers and payers. |
||||||||
|
Joel Gelfand, MD Associate Professor of
Dermatology and Epidemiology University of Pennsylvania Joel M. Gelfand, MD, MSCE, is an Associate Professor of Dermatology and Epidemiology (tenured) at the University of Pennsylvania’s Perelman School of Medicine. He is principal investigator of three large NIH funded psoriasis projects: The Dermatology Clinical Effectiveness Research Network (DCERN) which evaluates the effectiveness of psoriasis treatments under real world conditions, the Incident Health Outcomes and Psoriasis Events (iHOPE) study which is a population based prospective study of 9000 psoriasis patients and 90,000 controls nested within an electronic medical records system in the United Kingdom in which general practitioners have provided specific information about psoriasis history and body surface area affected, and the Vascular Inflammation in Psoriasis Trial (VIP) which is a multi-center, interventional trial evaluating the impact of a TNF inhibitor, phototherapy, and placebo on vascular inflammation and lipid metabolism. He is a nationally and internationally recognized expert in psoriasis, clinical epidemiology, drug safety, and clinical trials. Dr. Gelfand is the author of over 100 scientific publications (cited over 9000 times, H index 43) which appear in journals such as JAMA, BMJ, European Heart Journal, Annals of Rheumatology, JAMA Dermatology, JAAD, and the JID. He is the recipient of the American Skin Association’s Psoriasis Achievement Award, PENN’s Marjorie Bowman Award, and is an elected member of the American Society for Clinical Investigation. He has given over 10 named lectureships and keynote addresses including the Society for Investigative Dermatology’s Eugene M. Farber lecture. He has received grant support from NIH (F32, K23, RC1, 3 R01’s, K24), FDA (R01), the Dermatology Foundation, the American Skin Association, the National Psoriasis Foundation, and numerous pharmaceutical companies to support his independent research program. The overarching goal of his research and clinical practice is to improve psoriasis patient outcomes in the skin and joints, while lowering the risk of diabetes, CV disease and mortality. |
||||||||
|
John M. Harris, MBA Principal DGA Partners John Harris is a Principal with DGA Partners, a healthcare management consulting firm. John is a frequent speaker on payer-provider alignment and accountable care for several organizations, including the American Association of Integrated Health Delivery Systems and the Healthcare Financial Management Association. John has also co-authored articles on innovative payment models in Futurescan 2015 and the journal Healthcare Financial Management including “Choosing your Strategy for Value-based Competition,” “Finance Leadership Imperatives in Clinical Redesign,” and “The Transition to Emerging Revenue Models.” He spends much of his time facilitating strategic discussions or analyzing financial arrangements between physicians, hospitals, and health plans seeking to improve quality and cost-effectiveness. In addition to consulting, John’s 25 years of health care experience includes senior management positions with providers, health policy work, and the successful launch of a national health information storage and access company. John has a BA from Dartmouth College and an MBA in Health Care Management from the Wharton School of the University of Pennsylvania. |
||||||||
|
Dawn Holcombe, MBA, FACMPE President DGH Consulting Dawn Holcombe, President of DGH Consulting, has experience in strategic direction, environmental assessment, payer trends and relations, practice strategy and operations, quality/value programs, physician networks and state association issues, and business development, especially in the field of oncology. Dawn Holcombe’s thirty years in healthcare have included executive, strategic, financial, and marketing positions in academic and private health systems as well as physician practices. She is the Editor of the national Oncology Practice Management journal, a past President of the national Administrators in Oncology Hematology Assembly (AOHA) of the Medical Group Management Association (MGMA) and is a Fellow in the American College of Medical Practice Executives (ACMPE), earning her MBA at the University of Michigan. Mrs. Holcombe is uniquely qualified to address the issues and perspectives regarding oncology and payers, as the author of the National Association of Managed Care Physicians (NAMCP) Medical Director’s Guide: Oncology. Mrs. Holcombe is a popular speaker for several national conferences, corporate meetings, and speakers’ bureaus for provider, employer and payer audiences. |
||||||||
|
Robert W. Hull, MD Associate Professor Medicine West Virginia University School of Medicine Robert W. Hull, MD is an Associate Professor of Medicine at West Virginia University as well as the Director of Heart Failure in the Division of Cardiology and Co-Director of Arrhythmia Service at West Virginia University Hearth Institute. He is Board Certified through the American Board of Internal Medicine (ABIM) in Clinical Cardiac Electrophysiology, Cardiovascular Disease, and Internal Medicine. In 2014 he was honored by the American Heart Association (AHA) with the Heart Failure Gold Plus Quality Achievement Award and received the Quality Blue Award for Heart Failure from Highmark Blue Cross/Blue Shield in 2013. Dr. Hull proudly served in the United States Army for over 10 years, is a member of several medical associations and clinical affiliations, and serves on multiple medical committees. He is an accomplished clinical researcher, having published national and international abstracts on Heart Failure as well as countless manuscripts in peer reviewed medical journals. Dr. Hull is a frequent presenter and consultant contributing expert guidance on Heart Failure and continues to be recognized as a leading specialist in the Cardiac industry. |
||||||||
|
Jonathan Kaufman, MD Medical Director Winship Cancer Institute Jonathan L. Kaufman, MD, is board certified in hematology and medical oncology. Dr. Kaufman is an active clinical and translational researcher in the fields of Multiple Myeloma, Amyloidosis, and bone marrow transplant. As a network physician, he started practicing with Emory Healthcare in 2005. Dr. Kaufman is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He also holds memberships with American Society of Clinical Oncology and American Society of Hematology. |
||||||||
|
Christopher Lloyd Memorial Hermann with The Chartis Group CEO MHMD- The Memorial Hermann Physician Network CEO MHACO- The Memorial Hermann Accountable Care Network Christopher Lloyd is the CEO of MHMD, the physician network for the Memorial Hermann Healthcare System, located in Houston, Texas as well as the CEO of Memorial Hermann Accountable Care Organization (MHACO). Chris has over 25 years of executive experience in acute health care settings. Prior to assuming his current role in May 2009, Chris was recruited to Memorial Hermann in 20114 as the chief operations officer at the 900-bed academic Memorial Hermann Hospital in the Texas Medical Center. He has also served as chief of the neurosciences service line. Chris also worked for Catholic Healthcare West (CHW), serving at St. Joseph’s Hospital as vice president of operations in Phoenix, Arizona. Prior to CHW, Chris worked for 11 years at Advocate Healthcare in Chicago, III., running hospital operations and a large multispecialty physician group. |
||||||||
|
Brigitte Nettesheim The Chartis Group Principal and Payor Segment Lead Brigitte Nettesheim is a principal with The Chartis Group and the leader of the payor segment in the Accountable Care Solutions practice. Ms. Nettesheim brings deep experience working with healthcare providers to design and implement accountable care organizations (ACO). Before joining the Chartis Group, she served as regional head of strategy and operations for Aetna’s Accountable Care Solutions (ACS) division. In this role, Ms. Nettesheim helped build Aetna’s ACS division, including negotiation and leading the development of eight successful provider partnerships and its most successful collaboration with Banner Health in Phoenix, Arizona. In addition, Ms. Nettesheim served as Aetna’s market-facing expert on strategy and implementation of ACO partnerships leading numerous speaking engagements for a variety of audiences such as healthcare panels, benefit consulting firms and plan sponsor forums. Currently, she serves as an insurance industry expert for Modern Healthcare magazine specializing in provider engagement strategies. |
||||||||
|
Gary Owens, MD Consultant Gary Owens Associates Dr. Gary Owens has 30 years of experience in healthcare management. He has literally seen the evolution of the healthcare industry from the days of indemnity insurance in the 1980s, through the managed care movement of the 1990s to the current era of health care coverage and payment reform. Dr. Owens served as the Vice President of Medical Management and Policy at Independence Blue Cross for 22 years with responsibilities for medical and pharmacy management, technology evaluation and medical policy. Among his accomplishments at IBC was the development of their medical policy process with on-line access, the launch of a coordinated care management approach to medical management, and the 2006 launch of FutureScripts, IBC’s wholly owned PBM. Forming his own consulting practice in 2007, he provides strategic and tactical consulting services to a wide range of clients. As a part of his consulting practice, he is the co-developer of Towers Watson’s Reference Formulary System and its associated management programs and advisor to their pharmacy practice and he has provided consultative services to over 30 pharmaceutical, diagnostic and device manufacturers regarding launch and reimbursement issues pertaining to managed care. |
||||||||
|
Craig Pederson Principal, Sullivan, Cotter and Associates, Inc. Craig Pederson is currently the Principal at Sullivan Cotter and Associates, a firm specializing in executive, employee and physician compensation and benefits for the health care industry. Craig is a results-oriented and forward-thinking top health care leader with extensive experience in corporate strategy, business development, physician/hospital alignment, system restructuring, and physician compensation methodologies. Mr. Pederson is an innovative strategy consultant who assesses, diagnoses, and solves complex business issues; ultimately helping key leaders make tough decisions to increase functionality and profit. Craig is affiliated with several medical group management associations, is a frequent speaker and has published commentary in medical journals. |
||||||||
|
Timothy Reid, MD Diabetes & Metabolism Specialist Mercury Health System Dr. Timothy Reid is a Board Certified Family Physician practicing at the Mercy Diabetes Center in Janesville, Wisconsin. He received his Medical Training at the Medical College of Ohio, graduating in 1989. He did his Family Medicine Residency training at St. Elizabeth Medical Center in Covington, KY. He has been in practice for the last 22 years. Dr. Reid was instrumental in the development of the Mercy Diabetes Center in 2003. He sits on numerous committees relating to diabetes care within Mercy Health System. Dr. Reid was the past editor of the journal Insulin and the Diabetes Journal Club. Dr. Reid is active in his community volunteering on American Diabetes Association’s annual Wisconsin State Diabetes Educator’s Meeting. Dr. Reid speaks nationally on many diabetes related topics. He and his wonderful wife of 25 years have four children, triplets who are 19 years old (two girls and a boy) and a 15 year old daughter. |
||||||||
|
Sheryl Riley, RN, OCN, CMCN Director, Clinical Services SAI Systems, International, Inc. Sheryl Riley is the Director of Clinical Services for SAI Systems International, Inc. Sheryl is part of a clinical team that focuses on care management including oncology and chronic care, transitions of care, patient centered medical home (PCMH), accountable care organizations (ACOs), software and electronic health records. Sheryl has been instrumental in the development and design of the oncology care management software as well as continues to utilize her clinical and operational expertise to assist in the further development and design of software products for SAI systems. Sheryl has been a practicing nurse clinician for over 25 years. She has experience in strategic business and partnership development, clinical oncology and nurse navigation, disease care, and population management. She is also an accomplished author having written over 22 different disease management programs and countless articles in various journals. Sheryl has been a member of many national and local committees and associations. She is also an active member of the American Association of Managed Care Nurses where she was President, member of the board as well as chair and co-chair of committees. |
||||||||
|
Jennifer Robinson, MD, MPH Professor Epidemiology University of Iowa Jennifer G. Robinson, MD, MPH is a Professor in the Departments of Epidemiology and Medicine (Division of Cardiology), and Director of the Prevention Intervention Center at the University of Iowa, Iowa City, Iowa. As an active researcher, Dr. Robinson has performed numerous clinical trials sponsored by the National Institutes of Health and the pharmaceutical industry. She was co-principal investigator for the Women's Health Initiative (WHI) at the University of Iowa as well as principal investigator for the WHI ancillary studies, including the WHI-Mental Status MRI, WHI Study of Cognitive Aging, and the WHI-Coronary Artery Calcium studies. She has conducted extensive research on wide range anti-atherosclerotic and metabolic agents, including lipid-modifying, anti-inflammatory, antihypertensive, weight loss, and diabetic treatments as well as Postmenopausal hormone therapy. Dr. Robinson has published over 145 peer-reviewed articles in the area of lipids-modifying drugs, cardiovascular risk stratification, and cardiovascular prevention. She has lectured widely on preventive cardiology and the diagnosis and treatment of disorders of lipid metabolism. She was Vice-Chair for the 2013 American Heart Association/ American College of Cardiology Cholesterol Guidelines (formerly known as the National Cholesterol Education Program Adult Treatment Panel IV) and a member of the 2013 American Heart Association/American College of Cardiology Risk Reduction Guidelines (formerly known as the National Heart, Lung, and Blood Institute Risk Reduction Working Group). While at the University of Minnesota in Minneapolis, Dr. Robinson received her medical degree and completed an Internal Medicine residency with the College of Medicine, and received a Master's of Public Health from the College of Public Health. She is a diplomat of the American Boards of lnternal Medicine and Clinical Lipidology. |
||||||||
|
Joel R. Rosh, MD Director Pediatric
Gastroenterology Goryeb Children’s Hospital - Atlantic Health System Joel R. Rosh, MD, is a Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai, New York, and Director of the Division of Pediatric Gastroenterology and Nutrition at Goryeb Children’s Hospital of the Atlantic Health System in Morristown, New Jersey. He received an Honors degree from Brown University and earned his medical degree at the Albert Einstein College of Medicine in Bronx, New York, followed by an internship and residency in Pediatrics at Babies Hospital/Columbia-Presbyterian Medical Center in New York, New York. Dr. Rosh completed a fellowship in Pediatric Gastroenterology at Mt. Sinai Hospital in New York. He is certified by the American Board of Pediatrics in Pediatric Gastroenterology and Nutrition. Dr. Rosh is a Fellow of the American Gastroenterological Association and the American College of Gastroenterology and has served in leadership and national positions for the American Academy of Pediatrics, the Crohn’s & Colitis Foundation of America, and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition. Dr. Rosh currently serves on the editorial boards of the Journal of Pediatric Gastroenterology and Nutrition, and the Journal of Gastroenterology. Dr. Rosh is widely published in the field of Pediatric Gastroenterology with special interest in Inflammatory Bowel Disease and the optimization of emerging therapies. |
||||||||
|
Joseph Shega VITAS Healthcare Regional Medical Director Joseph Shega is the regional medical director for VITAS Healthcare for the states of Georgia, Alabama, and Florida. He completed his Medical School at Northwestern University, Internal Medicine Residency at the University of Pittsburgh, and his Geriatrics fellowship at the University of Chicago. His clinical and research goals aim at improving the care of patients with advanced illness through the integration of palliative care and hospice. Dr. Shega has numerous peer-reviewed publications and book chapters related to this topic. He serves as the Chair of the Ethics Committee at the American Geriatrics Society and the Nominating Committee for the American Academy of Hospice and Palliative Medicine along with the Editorial Boards of Pain Medicine and the Journal of Pain and Symptom Management. He resides in Gotha near Orlando with his partner and 2 kids. |
||||||||
|
David Sontag, PhD Assistant Professor, Computer Sciences, New York University Dr. Sontag is an Assistant Professor in NYU's Computer Science department, part of the Courant Institute of Mathematical Sciences. His research focuses on machine learning and probabilistic inference. His group is particularly interested in machine learning problems motivated by clinical medicine. For example, they are developing algorithms to learn probabilistic models for medical diagnosis directly from unstructured clinical data, automatically discovering and predicting latent (hidden) variables. His team collaborates with the Emergency Medicine Informatics Research Lab at Beth Israel Deaconess Medical Center and with Independence Blue Cross. Previously, he was a post-doc at Microsoft Research New England. His PhD is in Computer Science from MIT, where he worked with Tommi Jaakkola on approximate inference and learning in probabilistic models. Dr. Sontag received his bachelor’s degree is from UC Berkeley, in Computer Science, where he worked with Stuart Russell's First-Order Probabilistic Logic group. |
||||||||
|
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD Faculty, Thomas Jefferson University School of Population Health Dr. Stefanacci has focused his career on care improvement of at risk populations through innovative care delivery. His expertise in this area comes in part from serving as the American Geriatric Society (AGS) Health Policy Scholar at the Centers for Medicare and Medicaid Services (CMS). He remains active with CMS currently serving on a technical advisory committee examining changes to Medication Therapy Management (MTM). Today after spending a decade as Associate Professor at the University of the Sciences, home of the oldest college of pharmacy in the United States; Dr. Stefanacci moved his academic affiliation to Thomas Jefferson University School of Population Health in Philadelphia, PA. His managed care experience includes more than a decade as a medical director for various organizations, including a large primary care private practice, a full-risk provider group, and several geriatric managed care organizations. Currently, Dr. Stefanacci continues clinical practice with the Program All-inclusive Care of the Elderly (PACE). |
||||||||
|
Gillian Woollett, MA, DPhil Senior Vice President Avalere Health Gillian Woollett, MA, DPhil, is the Senior Vice President of Avalere Health, leading our FDA Practice. She provides the "prequel" of scientific and regulatory strategic policy expertise that supports medicinal products gaining approval at the FDA in a manner that allows them to be successful in the public and private reimbursement world. She is building a bridge for Avalere clients from the FDA space into the traditionally separate Centers for Medicare & Medicaid Services and healthcare policy/business world. Prior to joining Avalere, Gillian was Chief Scientist at Engel & Novitt, LLP, and was Vice President, Science and Regulatory Affairs at the Biotechnology Industry Organization (BIO). She joined BIO after being Associate Vice President at the Pharmaceutical Research and Manufacturers of America. She has been an appointee on federal advisory committees to the CDC and the Department of Commerce. Trained as a molecular biologist/immunologist, Gillian publishes in peer-reviewed literature on biotechnology topics, and is a frequent speaker on emerging biosciences and their ability to support better and more focused therapies. Gillian has a BA, MA in the Natural Sciences Tripos (Biochemistry) from the University of Cambridge, and a DPhil in Immunology from the University of Oxford. |
||||||||
|
R. Scott Wright, MD, FACC, FESC, FAHA Professor of Medicine Mayo Clinic Dr. R. Scott Wright is a Professor of Medicine and a Consultant in Cardiology at the Mayo Clinic in Rochester, MN. His work at Mayo Clinic has focused on Acute Coronary Syndromes, Preventive Cardiology and Clinical Trial design and research. Dr. Wright graduated with his bachelor’s degree and his Doctorate of Medicine from the University of Kentucky and did his post-medical school training in Internal Medicine, Clinical Investigation and Fellowship in Cardiovascular diseases at the Mayo Clinic in Rochester, MN. Professor Wright has authored over 100 original articles and book chapters in the field of cardiovascular medicine. He has worked on a large number of clinical trials and has been a member of the Steering Committee of many of them. He has chaired an Institutional Review Board at Mayo Clinic for many years and also chairs the Pharmacy and Therapeutics Cardiovascular Task Force. Professor Wright has been active in a number of medical organizations including serving as a Delegate to the American Medical Association in the 1990’s and serving on the Board of Trustees of the Minnesota Medical Association. He has led the most recent ACC/AHA Guidelines Task Force for Update on Unstable Angina/Non-ST Myocardial Infarction. Dr. Wright has also been active in his community. He was appointed by the Governor of Minnesota in 2007 to serve on the Health Care Transformation Task Force. He has served as a health care policy advisor to two members of Congress in the recent past as well as testified previously before the United States Senate on policy issues. He has been an invited speaker on health care policy by governments in Asia and the USA. He and his wife have four children and make their home in Rochester, Minnesota. |
||||||||
